SCHEMBL1694728

SCHEMBL1694728

N#Cc1c(N)ncnc1NCCc1nc2c(F)cccc2cc1C(=O)N1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 8/20 0.42
PIK3R2 O00459 4/20 0.38
PIK3CA P42336 4/20 0.37
PIK3CD O00329 4/20 0.37
PIK3CB P42338 4/20 0.37
PIK3CG P48736 4/20 0.37
ABCC1 P33527 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
MAP4K2 Q12851 1/20 0.36
HASPIN Q8TF76 1/20 0.36
CDK19 Q9BWU1 1/20 0.36
CYP2D6 P10635 1/20 0.35
HPGD P15428 1/20 0.35
RPS6KB1 P23443 1/20 0.35
MTOR P42345 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1694730 0.99 CDK1 (0.43) CDK1PIK3R2PIK3CAPIK3CDPIK3CB
SCHEMBL1694805 0.93 PIK3CA (0.45) CDK1PIK3R2PIK3CAPIK3CDPIK3CB
SCHEMBL1694917 0.93 CDK1 (0.45) CDK1PIK3R2PIK3CAPIK3CDPIK3CB
SCHEMBL1694753 0.88 PIK3R2 (0.39) PIK3R2PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL1694831 0.84 PIK3CD (0.43) PIK3R2PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL1695139 0.84 PIK3R2 (0.45) PIK3R2PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL1695297 0.82 ADORA2A (0.39) PIK3R2PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL1695323 0.81 PIK3CD (0.37) PIK3R2PIK3CDHPGD
SCHEMBL1695191 0.81 PIK3CD (0.40) CDK1PIK3R2PIK3CAPIK3CDPIK3CB
SCHEMBL14816051 0.80 PIK3CD (0.51) PIK3R2PIK3CAPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588467-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003274-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed